The Role of Growth Factors Present in Umbilical Cord Blood Plasma and Serum in Stimulating Tissue Regeneration and Regulating Glucose Metabolic Pathways: A Novel Strategy for the Treatment of Insulin‑Resistant Diabetes
The Role of Growth Factors Present in Umbilical Cord Blood Plasma and Serum in Stimulating Tissue Regeneration and Regulating Glucose Metabolic Pathways: A Novel Strategy for the Treatment of Insulin‑Resistant Diabetes
Mahdieh Alsadat Alboshokeh1
1) Department of Biochemistry, Faculty of Basic Sciences, Islamic Azad University, Shahrood Branch, Shahrood Iran.
IOI Code
:
ABEB-ABGAGD
Publication :
4th International Conference on Recent Advances in Engineering, Innovation and Technology - Belgium(eitconf.com)
Abstract :
Insulin‑resistant diabetes is a complex metabolic disorder characterized not only by impaired insulin signaling but also by chronic inflammation, mitochondrial dysfunction, vascular insufficiency, and reduced tissue regenerative capacity. Conventional antidiabetic therapies primarily focus on glycemic control and often fail to address the underlying cellular and microenvironmental abnormalities that drive disease progression. In recent years, regenerative medicine has emerged as a complementary strategy, and umbilical cord blood plasma and serum have attracted increasing attention due to their rich composition of growth factors, cytokines, metabolites, and extracellular vesicles with potent biological activity. The objective of this review is to critically evaluate the role of growth factors present in umbilical cord blood plasma and serum in stimulating tissue regeneration and regulating glucose metabolic pathways, with particular emphasis on their potential application in the treatment of insulin‑resistant diabetes. The review synthesizes experimental, preclinical, and translational evidence to elucidate the mechanistic links between regenerative signaling and metabolic regulation. A comprehensive analysis of the literature was conducted focusing on the biological composition of umbilical cord blood‑derived products, their effects on insulin signaling pathways, mitochondrial function, angiogenesis, immune modulation, and tissue repair in insulin‑responsive organs such as skeletal muscle, liver, and adipose tissue. Emphasis was placed on mechanistic studies and preclinical models that clarify how these bioactive factors influence systemic glucose homeostasis. The findings indicate that umbilical cord blood plasma and serum enhance insulin sensitivity through activation of key signaling pathways, including PI3K/Akt, suppression of chronic inflammation, improvement of vascularization, and restoration of cellular metabolic flexibility. Additionally, extracellular vesicles and exosomes appear to mediate long‑lasting metabolic reprogramming through epigenetic and post‑transcriptional mechanisms. Importantly, these effects occur without inducing hypoglycemia or excessive insulin secretion. In conclusion, umbilical cord blood plasma and serum represent a promising regenerative‑metabolic therapeutic platform capable of addressing the multifactorial pathophysiology of insulin‑resistant diabetes.
Keywords : umbilical cord blood plasma insulin resistance tissue regeneration growth factors glucose metabolism